To market your biocidal products, you have to submit an authorisation dossier. There are three types of authorisation of marketing. This can be national, in other words, specific to a single Member State (with the possibility of mutual recognition if you market your product in other countries of the European Union), or may arise from the Union European: we then speak of a EU authorisation.
Regarding national authorisation, the applicant shall submit an application to the competent authority of the country. The National Authority has 1 year to validate or reject the request
After the authorisation, the applicant may then apply for mutual recognition if he wishes to market the product in other EU countries.
The authorisation of the Union allows placing biocidal products on the entire European market after a year without obtaining a specific national authorisation. However this authorisation only applies to new active substances. The existing active substances may be permitted only during the regulatory deadlines. The next is 1 January 2017 and concerns the TP 2, 6 and 13. Duration of authorisation : The authorisation is valid for five years, renewal is valid for life. The applicant shall submit an application to the competent authority of the country where it wishes to sell its product. The duration of the authorisation varies depending on the biocidal product. For more information please refer to the table "duration of authorisation" at the bottom of this page.
The French government by ministerial decree of 13 June 2014 fixed the amount of compensation due for approval and authorisation of the marketing of biocidal substances and products.
In accordance with Article 9 of Regulation (EU) No 528/2012 you must pay the following amounts:
In accordance with Article 14 of Regulation (EU) No 528/2012 you must pay the following amounts:
Implementation of 2 of Article 55 of Regulation (EU) No 528/2012:
Implementation of Article 30 or Article 43 of Regulation (EU) No 528/2012:
Implementation of Article 31 or Article 45 of Regulation (EU) No 528/2012:
Implementation of Article 25 of Regulation (EU) No 528/2012:
Implementation of Article 25 of Regulation (EU) No 528/2012:
Implementation of Article 25 of Regulation (EU) No 528/2012:
Implementation of Articles 33 or 34 of Regulation (EU) No 528/2012:
Implementation of Article 31 of Regulation (EU) No 528/2012:
Implementation of Article 7 of the Implementing Regulation (EU) No 354/2013:
Implementation of Article 9a of Implementing Regulation (EU) No 354/2013:
Implementation of Article 8 or Article 13 of the Implementing Regulation (EU) No 354/2013:
Implementation of Article 9a of Implementing Regulation (EU) No 354/2013:
In accordance with Article 6 of Implementing Regulation (EU) No. 354-2013:
In accordance with Article 5 or Article 6 of Implementing Regulation (EU) No 414/2013:
Implementation of Article 6 of Implementing Regulation (EU) No 354-2013
Implementation of Article 17 of Regulation (EU) No 528/2012:
Implementation of 2 of Article 56 of Regulation (EU) No 528/2012
Mise en application du 3 de l'article 56 du R�glement (UE) n� 528/2012
Implementation of Article 53 of Regulation (EU) No 528/2012:
Accordance with Article 23 of Regulation (EU) No 528/2012 is required
Table : A substance is approved for the following periods:
Duration of approvalRenewal PeriodActive SubtanceMax 10 yearsMax 15 yearsActive substance fulfilling the criteria for exclusion (Article 5)Max 5 ansNAActive substance that candidates for substitutionMax 7 yearsMax 7 years
Table : Period of authorisation
Biocidal ProductMax 10 yearsBP containing AS which are candidates for substitutionMax 5 yearsBP containing a new AS*Max 3 years
*Under the conditions defined in Article 55 paragraph 2
Any questions on your biocidal project? Want to get a detailed quote? Please contact us at contact@ecomundo.eu
To market your biocidal products, you have to submit an authorisation dossier. There are three types of authorisation of marketing. This can be national, in other words, specific to a single Member State (with the possibility of mutual recognition if you market your product in other countries of the European Union), or may arise from the Union European: we then speak of a EU authorisation.
Regarding national authorisation, the applicant shall submit an application to the competent authority of the country. The National Authority has 1 year to validate or reject the request
After the authorisation, the applicant may then apply for mutual recognition if he wishes to market the product in other EU countries.
The authorisation of the Union allows placing biocidal products on the entire European market after a year without obtaining a specific national authorisation. However this authorisation only applies to new active substances. The existing active substances may be permitted only during the regulatory deadlines. The next is 1 January 2017 and concerns the TP 2, 6 and 13. Duration of authorisation : The authorisation is valid for five years, renewal is valid for life. The applicant shall submit an application to the competent authority of the country where it wishes to sell its product. The duration of the authorisation varies depending on the biocidal product. For more information please refer to the table "duration of authorisation" at the bottom of this page.
The French government by ministerial decree of 13 June 2014 fixed the amount of compensation due for approval and authorisation of the marketing of biocidal substances and products.
In accordance with Article 9 of Regulation (EU) No 528/2012 you must pay the following amounts:
In accordance with Article 14 of Regulation (EU) No 528/2012 you must pay the following amounts:
Implementation of 2 of Article 55 of Regulation (EU) No 528/2012:
Implementation of Article 30 or Article 43 of Regulation (EU) No 528/2012:
Implementation of Article 31 or Article 45 of Regulation (EU) No 528/2012:
Implementation of Article 25 of Regulation (EU) No 528/2012:
Implementation of Article 25 of Regulation (EU) No 528/2012:
Implementation of Article 25 of Regulation (EU) No 528/2012:
Implementation of Articles 33 or 34 of Regulation (EU) No 528/2012:
Implementation of Article 31 of Regulation (EU) No 528/2012:
Implementation of Article 7 of the Implementing Regulation (EU) No 354/2013:
Implementation of Article 9a of Implementing Regulation (EU) No 354/2013:
Implementation of Article 8 or Article 13 of the Implementing Regulation (EU) No 354/2013:
Implementation of Article 9a of Implementing Regulation (EU) No 354/2013:
In accordance with Article 6 of Implementing Regulation (EU) No. 354-2013:
In accordance with Article 5 or Article 6 of Implementing Regulation (EU) No 414/2013:
Implementation of Article 6 of Implementing Regulation (EU) No 354-2013
Implementation of Article 17 of Regulation (EU) No 528/2012:
Implementation of 2 of Article 56 of Regulation (EU) No 528/2012
Mise en application du 3 de l'article 56 du R�glement (UE) n� 528/2012
Implementation of Article 53 of Regulation (EU) No 528/2012:
Accordance with Article 23 of Regulation (EU) No 528/2012 is required
Table : A substance is approved for the following periods:
Duration of approvalRenewal PeriodActive SubtanceMax 10 yearsMax 15 yearsActive substance fulfilling the criteria for exclusion (Article 5)Max 5 ansNAActive substance that candidates for substitutionMax 7 yearsMax 7 years
Table : Period of authorisation
Biocidal ProductMax 10 yearsBP containing AS which are candidates for substitutionMax 5 yearsBP containing a new AS*Max 3 years
*Under the conditions defined in Article 55 paragraph 2
Any questions on your biocidal project? Want to get a detailed quote? Please contact us at contact@ecomundo.eu